Citadel Advisors’s Gritstone bio, Inc. Common Stock GRTS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-67,786
| Closed | -$38K | – | 15534 |
|
|
2024
Q2 | $41.9K | Sell |
67,786
-96,407
| -59% | -$81.5K | ﹤0.01% | 11953 |
|
|
2024
Q1 | $422K | Sell |
164,193
-140,379
| -46% | -$343K | ﹤0.01% | 8750 |
|
|
2023
Q4 | $621K | Sell |
304,572
-48,167
| -14% | -$87.9K | ﹤0.01% | 7634 |
|
|
2023
Q3 | $607K | Sell |
352,739
-87,609
| -20% | -$156K | ﹤0.01% | 7637 |
|
|
2023
Q2 | $859K | Sell |
440,348
-117,417
| -21% | -$275K | ﹤0.01% | 6776 |
|
|
2023
Q1 | $1.55M | Buy |
557,765
+169,950
| +44% | +$486K | ﹤0.01% | 5853 |
|
|
2022
Q4 | $1.34M | Sell |
387,815
-57,795
| -13% | -$165K | ﹤0.01% | 6260 |
|
|
2022
Q3 | $1.15M | Sell |
445,610
-59,377
| -12% | -$189K | ﹤0.01% | 6695 |
|
|
2022
Q2 | $1.22M | Sell |
504,987
-134,509
| -21% | -$353K | ﹤0.01% | 6560 |
|
|
2022
Q1 | $2.63M | Buy |
639,496
+292,415
| +84% | +$1.55M | ﹤0.01% | 5468 |
|
|
2021
Q4 | $4.46M | Buy |
347,081
+133,961
| +63% | +$1.48M | ﹤0.01% | 4525 |
|
|
2021
Q3 | $2.3M | Buy |
213,120
+179,619
| +536% | +$1.63M | ﹤0.01% | 6000 |
|
|
2021
Q2 | $306K | Sell |
33,501
-416,695
| -93% | -$3.85M | ﹤0.01% | 11213 |
|
|
2021
Q1 | $4.25M | Buy |
+450,196
| New | +$6.2M | ﹤0.01% | 4635 |
|
|
2020
Q3 | – | Sell |
-77,750
| Closed | -$517K | – | 10895 |
|
|
2020
Q2 | $517K | Sell |
77,750
-23,070
| -23% | -$155K | ﹤0.01% | 7012 |
|
|
2020
Q1 | $587K | Buy |
100,820
+5,719
| +6% | +$48K | ﹤0.01% | 6201 |
|
|
2019
Q4 | $853K | Buy |
95,101
+4,725
| +5% | +$39.4K | ﹤0.01% | 5888 |
|
|
2019
Q3 | $780K | Sell |
90,376
-56,840
| -39% | -$574K | ﹤0.01% | 6018 |
|
|
2019
Q2 | $1.64M | Buy |
147,216
+74,395
| +102% | +$851K | ﹤0.01% | 4857 |
|
|
2019
Q1 | $969K | Buy |
72,821
+60,450
| +489% | +$808K | ﹤0.01% | 5649 |
|
|
2018
Q4 | $191K | Sell |
12,371
-51,935
| -81% | -$991K | ﹤0.01% | 7900 |
|
|
2018
Q3 | $916K | Buy |
+64,306
| New | +$916K | ﹤0.01% | 5699 |
|
Other funds holding GRTS
Citadel Advisors's GRTS Position: Q3 2024 in Review
Citadel Advisors sold out of Gritstone bio, Inc. Common Stock (GRTS) in Q3 2024, closing a stake of 67,786 shares — an estimated $38K sold.
Citadel Advisors first reported a position in GRTS in Q3 2018 and held it in 22 quarters. The position peaked at $4.46M in Q4 2021. 56 funds tracked by Wall St. Rank hold GRTS as of Q3 2024.
- Citadel Advisors reported no remaining Gritstone bio, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
- Citadel Advisors sold 67,786 Gritstone bio, Inc. Common Stock shares in Q3 2024, an estimated $38K.
- Citadel Advisors first reported a position in Gritstone bio, Inc. Common Stock in Q3 2018 and held it in 22 quarters.
- Citadel Advisors's Gritstone bio, Inc. Common Stock position peaked at $4.46M in Q4 2021.
- 56 funds tracked by Wall St. Rank held Gritstone bio, Inc. Common Stock as of Q3 2024.
Based on Citadel Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.